Home
  • home
  • boards
  • job center
  • news archives
  • chat
  • networking
  • overheard
  • pharmagather
  • advertise
  • contact us





  • cafepharma news hand selected daily
  • get news headlines in your inbox each weekday
Home

MS

Tagged:  
  • Biogen
  • FDA
  • MS
  • multiple sclerosis
  • social media
  • Tysabri
Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching
BNET Pharma
  • Login or register to post comments
Tagged:  
  • Avanir
  • MS
  • multiple sclerosis
  • Zenvia
Avanir shares jump on new Zenvia data
Fierce Biotech
  • Login or register to post comments
Tagged:  
  • Copaxone
  • lawsuits
  • Momenta
  • MS
  • multiple sclerosis
  • Sandoz
  • Teva
Teva says it wants to add 3 more patents to suit against Moment and Sandoz over Copaxone
Yahoo/AP
  • Login or register to post comments
Tagged:  
  • Biogen
  • Elan
  • MS
  • PML
  • Tysabri
Elan, Biogen change Tysabri label due to PML risk
Reuters
  • Login or register to post comments
Tagged:  
  • Biogen
  • Elan
  • MS
  • multiple sclerosis
  • PML
  • Tysabri
More PML Troubles for Biogen, Elan MS Drug
TheStreet.com
  • Login or register to post comments
Tagged:  
  • Biogen
  • Elan
  • MS
  • multiple sclerosis
  • Tysabri
Reviving Tysabri
Forbes
  • Login or register to post comments
Tagged:  
  • Biogen
  • Elan
  • MS
  • multiple sclerosis
  • Tysabri
Whatever Tysabri Outcome, Biogen Idec Should Survive
BNET Pharma
  • Login or register to post comments
Tagged:  
  • Acorda
  • Fampridine-SR
  • FDA
  • MS
  • multiple sclerosis
FDA delays ruling on Acorda's MS drug until Jan. 22
Yahoo/AP
  • Login or register to post comments
Tagged:  
  • Elan
  • JNJ
  • MS
  • multiple sclerosis
  • Tysabri
Elan pins hopes on multiple sclerosis drug
FT.com
  • Login or register to post comments
Tagged:  
  • Acorda
  • Avanir
  • MS
Avanir, Acorda move on MS drug updates
Market Watch
  • Login or register to post comments
1234567next ›last »
Syndicate content

News Tags

Abbott Amgen Amylin Astra Zeneca Biogen biotech Bristol-Myers Squibb buyouts cancer Dendreon diabetes drug trials earnings Elan Eli Lilly FDA Genentech generics Genzyme Gilead GSK H1N1 healthcare reform JNJ Johnson and Johnson layoffs Lilly M&A Merck MS Novartis patents Pfizer Roche Sanofi-Aventis Schering-Plough swine flu Teva vaccines Wyeth
more tags

New on Cafepharma

  • Funny or interesting conversations reps hear in the field
    Overheard in the Field
  • Keep up with the latest at cafepharma:
    follow us on twitter
  • GE Healthcare IT
  • HIV Reps
  • New message boards
    Baxter IT
  • Pacific Pulmonary Services
  • Pacific Pulmonary Services IT
  • New message board category
    Pharma IT Boards



user login

  • Create new account
  • Request new password